About NASH Summit
Now in its 3rd year, the NASH Summit in Boston is the industry’s most comprehensive forum for advancing the development of successful NASH therapeutics. Focused on discovery through to late-stage clinical development of non-alcoholic steatohepatitis (NASH) candidate pipelines, the 3rd Annual NASH Summit Boston will bring together 300+ drug developers from 140+ organizations across 4 days of unparalleled content sharing and networking.
Covering every element from basic science to commercialization; the 3rd Annual NASH Summit with 57 industry leaders will present actionable takeaways on the next 12months of NASH drug development. The forum will provide you with the data, insight, and lessons needed to inform the acceleration of your NASH candidate pipeline:
- Contextualize the progress of the leading candidates beyond data alone to understand patient recruitment strategies, commercialization considerations and hurdles addressed prior to success.
- Understand how to build the confidence of investors and evaluate the payers’ perspective on reimbursement
- Improve drug efficacy in both early and late stage NASHby identifying and validating novel targets & drug mechanisms of action
Be part of the leading conversations and outline the next 12 months of your R&D and commercial decisions that will accelerate the development of your NASH candidate.
As competition in the NASH space increases, find out how you can move your candidate into differentiation and identify the best mode of action to stay ahead as this field looks to overcome its current limitations.